Pharma in South East Asia wins through innovation, M&A, JVs and strategic partnerships to spur marke

Rising demand for all categories of medicines, especially generic drugs.

During the last 10 years, South East Asia (SEA) pharmaceutical markets have been developing rapidly (6–10% yoy) and are expected to deliver remarkable future growth. Indonesia is the largest market in the region, followed by Thailand, the Philippines, Vietnam, Malaysia, and Singapore. A member of the G20 and with a population of 250 million people, Indonesia represents almost 40% of the SEA's economic output and the largest pharma manufacturing base in the entire region, although the country has more than 95% dependency on imports of pharma ingredients.

Concurrently, governments across SEA have been introducing universal healthcare programs. This is driving rising demand for all categories of medicines, especially generic drugs. Since launching its mandatory healthcare coverage program (JKN) in 2014, Indonesia's government healthcare spending has increased by 4%, and reached USD7.8 billion in 2016.

Nevertheless, success in the region will be fully achieved only if the strengths of the countries will be integrated and combined in a network of business partnerships, JVs, M&A that spur innovation, the development of high margin drugs, enhance markets penetration and ultimately create value over the board.

These factors have contributed to the success of CPhI SEA, the only trade exhibition dedicated to the pharma industry in the region. Held at Jakarta International Expo during March 22-24, 2017, CPhI SEA offers unparalleled content in a highly focused conference and additional features ranging from the South East Asian distributors' forum, the packaging forum, the innovation gallery and the investment forum. View the full conference program here.

The CPhI series of events drives growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.

More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Istanbul and Korea every year to exchange ideas, form alliances and conduct business on an international scale.